Development and Assessment of Trandolapril Immediate Release Tablets Employing Various Super-disintegrating Agents

Author:

Indurkhya Arpna,Patel Mahendra,Saraogi Gauravkant,Khan Masheer Ahmed

Abstract

Trandolapril is a powerful prodrug that does not contain sulfur and is converted into its active form, trandolaprilat, in the liver. Trandolapril has demonstrated efficacy and safety in treating mild-to-moderate essential hypertension in obese persons. The half-life of trandolapril and trandolaprilate is roughly 6 hours and 16-24 hours, respectively. This refers to the duration it takes for the concentration of these compounds to reduce by half due to elimination mechanisms. The aim of this study is to improve the composition of the Trandolapril immediate release tablet by integrating various types of supersintegrants. The optimization procedure utilized Crospovidone, sodium starch glycolate, and croscarmellose sodium as superdisintegrating agents. These agents were used at concentrations of 2%, 4%, and 6%. Nine formulations (IRTR 1 to IRTR 9) were created using the direct compression approach. The precompression parameters of all batches were assessed in relation to the set thresholds, and it was concluded that the powder blend had outstanding flow and compressibility characteristics. The tablets were assessed for post-compression properties, including hardness, drug content, and Disintegration Time (DT). A drug dissolution test was performed in a laboratory setting using 900 ml of hydrochloric acid (HCl) with a concentration of 0.1N. The test was completed at a controlled temperature of 37 ± 0.5°C. When formulating IRTR1-IRTR9, the disintegration time varied between 30.23 and 71.67 seconds. Additionally, over 70% of the medication was released during a 30-minute period. Therefore, after assessing many characteristics, it was concluded that the formulation of immediate release tablets of Trandolapril was successfully developed. The tablet designated IRTR3 demonstrated a disintegration time of 30.23, which is the shortest time it took to break down. Additionally, it achieved a drug release of 90.56% within a 30- minute period.

Publisher

Lloyd Institute of Management and Technology

Reference16 articles.

1. Peters DC, Noble S, Plosker GL. Trandolapril: An update of its pharmacology and therapeutic use in cardiovascular disorders. Drugs. 1998 Nov;56:871-93.

2. Benet LZ, Broccatelli F, Oprea TI. BDDCS applied to over 900 drugs. The AAPS journal. 2011; 13: 519-47.

3. Zannad F. Trandolapril: how does it differ from other angiotensin converting enzyme inhibitors. Drugs. 1993; 46(2): 172-82.

4. https://pubchem.ncbi.nlm.nih.gov/compound/ Trandolapril.

5. Rathore R, Kumar Gupta A, Parashar AK. Formulation and Evaluation of fast dissolving films of Granisetron Hydrochloride. Journal of Drug Delivery and Therapeutics. 2019;9(2):36–8.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3